Statements (59)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:alsoKnownAs |
Cognitive enhancers
Smart drugs |
gptkbp:coinedBy |
1972
Corneliu E. Giurgea |
gptkbp:controversy |
Efficacy debated
Long-term safety unknown |
gptkbp:effect |
Neurotransmitters
Neuroprotection Cerebral blood flow Brain metabolism |
gptkbp:example |
gptkb:Nicotine
gptkb:Rhodiola_rosea gptkb:Ginkgo_biloba gptkb:Modafinil gptkb:Panax_ginseng gptkb:Bacopa_monnieri Caffeine L-theanine Alpha-GPC Aniracetam Noopept Phenylpiracetam Piracetam |
https://www.w3.org/2000/01/rdf-schema#label |
Nootropics
|
gptkbp:includes |
Herbal supplements
Nutraceuticals Stimulants Adaptogens Ampakines Cholinergics Racetams |
gptkbp:legalStatus |
Prescription-only in some countries
Over-the-counter in some countries |
gptkbp:marketedAs |
Dietary supplements
Over-the-counter drugs Prescription drugs |
gptkbp:popularFor |
gptkb:Biohackers
Professionals Students Gamers |
gptkbp:regulates |
Varies by country
|
gptkbp:routeOfAdministration |
gptkb:Oral
Intranasal Sublingual |
gptkbp:sideEffect |
gptkb:Anxiety
gptkb:Insomnia Headache Gastrointestinal issues |
gptkbp:studiedIn |
gptkb:pharmacy
gptkb:Psychiatry Neuroscience |
gptkbp:usedFor |
Improving memory
Boosting motivation Enhancing cognitive function Improving creativity Increasing focus |
gptkbp:bfsParent |
gptkb:Human_Enhancement
|
gptkbp:bfsLayer |
6
|